Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1997 May 19;185(10):1769–1775. doi: 10.1084/jem.185.10.1769

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Ability of the anti-TGF-β (1D11.16) mAb to reverse LEWHgAmediated protection from mercury disease. Antilaminin antibody titer (A) and serum IgE concentration (B) in HgCl₂-injected rats (□, n = 5), and HgCl₂-injected rats 2 wk after adoptive transfer of the LEWHgA T cell line treated (▴, n = 4) or not (▪, n = 4) with the 1D11.16 anti-TGF-β mAb (2 mg at day −2, 0, 3, 6, and 9 with respect to the first HgCl₂ injection). The result is a pool of two independent experiments.